You are here

  • Home
  • Archive
  • Volume 22, Issue 4
  • Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation

Article metrics

Article menu
Download PDFPDF
Aetiology/Harm
Cohort study
Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation

 

Online download statistics by month:

Online download statistics by month: July 2017 to March 2024

AbstractFullPdf
Jul 201711749256
Aug 20177087939
Sep 20177451911
Oct 2017343144
Nov 20172722312
Dec 2017215122
Jan 2018249234
Feb 2018193137
Mar 2018298102
Apr 2018180124
May 2018214175
Jun 2018249199
Jul 201826276
Aug 2018280156
Sep 2018311178
Oct 2018297285
Nov 2018337194
Dec 2018350144
Jan 2019371193
Feb 2019518256
Mar 2019353254
Apr 2019453377
May 2019382181
Jun 2019251143
Jul 2019313297
Aug 2019291140
Sep 2019294187
Oct 2019441225
Nov 201929083
Dec 2019359111
Jan 2020332186
Feb 2020236151
Mar 2020256211
Apr 2020181151
May 2020165128
Jun 202010291
Jul 202012931
Aug 202010611
Sep 2020141144
Oct 2020220103
Nov 202018693
Dec 202011241
Jan 202124281
Feb 202119095
Mar 202116050
Apr 202113264
May 20218871
Jun 2021201614
Jul 20211081
Aug 20211141
Sep 202119173
Oct 2021246111
Nov 2021310173
Dec 2021142136
Jan 202214442
Feb 2022169104
Mar 202219161
Apr 202214641
May 2022281151
Jun 202215771
Jul 202216272
Aug 2022207112
Sep 202216272
Oct 2022199111
Nov 202220850
Dec 20226840
Jan 202311220
Feb 202312140
Mar 20237720
Apr 20234410
May 20238521
Jun 20236490
Jul 20236930
Aug 202311254
Sep 20236750
Oct 202358101
Nov 20236850
Dec 20237361
Jan 20243710
Feb 20243010
Mar 20248141
Total179211076331